Isolation of a Pseudomonas fluorescens metabolite/exotoxin active against both larvae and pupae of vector mosquitoes.
A formulation was developed from the metabolite(s) of a novel Pseudomonas fluorescens Migula strain (VCRC B426) and tested against 4th-instar larvae and pupae of three species of vector mosquitoes, Anopheles stephensi Liston, Culex quinquefasciatus Say and Aedes aegypti (L). The larvae and pupae of An. stephensi were the most susceptible to the formulation, followed by those of C. quinquefasciatus and Ae. aegypti, in that order, and the dosage requirement for pupal mortality was less than that required for larval mortality. The LC50 dosage requirements for larvae of these mosquito species were, respectively, 70.4, 511.5 and 757.3 microg protein ml(-1), whereas for pupae they were, respectively, 2.0, 9.4 and 19.2 microg protein ml(-1). The lethal fraction was purified from the culture broth and its molecular mass, as determined by high performance liquid chromatography, was 44kDa. This is the first report of a microbial formulation acting upon mosquito pupae, a non-feeding stage. Its mode of action and efficacy to control mosquitoes under field conditions need to be studied further.
Prabakaran
G
G
Vector Control Research Centre, Indian Council of Medical Research, Indira Nagar, Pondicherry-605 006, India. gprabha_99@yahoo.com
Paily
K P
KP
Padmanabhan
V
V
Hoti
S L
SL
Balaraman
K
K
D000818:Animals; D009033:Culicidae / Q000187:drug effects* / Q000254:growth & development*; D005098:Exotoxins / Q000494:pharmacology* / Q000633:toxicity; D007814:Larva / Q000187:drug effects; D007928:Lethal Dose 50; D010572:Pest Control, Biological; D011551:Pseudomonas fluorescens / Q000378:metabolism; D011679:Pupa / Q000187:drug effects
D005098:Exotoxins